Zimbabwe Launches Long-Acting HIV Prevention Drug Lenacapavir for High-Risk Groups
Feb 22, 2026Zimbabwe rolled out lenacapavir, a twice-yearly HIV prevention injection, on Thursday for high-risk populations including sex workers and adolescent girls. The donor-supported program will initially reach 46,000 people across 24 sites.